Biological processes, that is, HBV-related dysregulation of miRNA, are functionally associated with hepatocellular carcinoma (LIHC), reflecting the cancer subtyping potential of PAPD4 [50]. The gene discussed is TENT2; the disease is hepatocellular carcinoma.